Skip to content
AnalystLens

CENTENE CORP 8-K Report, Executive Changes (May 15, 2026)

Reports
Leadership Changes·Shareholder Matters
Filing Date
Filed May 15, 2026
Period End
May 12, 2026
Security
CNC
In the record · 2016–202610-K1110-Q328-K217

CNC filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 217 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Jul ’18Jul ’18
  2. Leadership change8-K · Jan ’20Jan ’20
  3. Deal closed8-K · Jan ’22Jan ’22
  4. Leadership change8-K · Aug ’25Aug ’25

Summary

Summary of the 8-K filed May 15, 2026. Cited figures are marked; the original filing is the authoritative source.

Centene Corporation (CNC) filed an 8-K on May 15, 2026, detailing the outcomes of its Annual Meeting of Stockholders held on May 12, 2026.

The report confirms the election of all nine director nominees for a one-year term, with strong support across the board. Additionally, shareholders provided a non-binding advisory vote of approval for the company's executive compensation and ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

Of note, a shareholder proposal requesting an independent board chairman was not approved. The filing also clarifies the company's executive officer positions following recent appointments, with Sarah London continuing as CEO and key leadership roles in Medicaid, Medicare, and other operational areas outlined.

Key Highlights

  1. All nine director nominees were overwhelmingly elected for a one-year term at the Annual Meeting.
  2. Shareholders approved the company's executive compensation in a non-binding advisory vote.
  3. KPMG LLP was ratified as Centene's independent registered public accounting firm for the fiscal year ending December 31, 2026.
  4. A shareholder proposal advocating for an independent board chairman was defeated.
  5. The report clarifies the current executive officer team, including recent appointments for Group President roles in Medicaid/Marketplace and Medicare/Specialty.
  6. A significant majority of common stock was represented at the Annual Meeting (412,968,059 shares).

Frequently Asked Questions

  1. What was the outcome of the director elections?

    All nine nominated directors were elected for a one-year term by a substantial majority of the votes cast at the Annual Meeting.

  2. Did shareholders approve the executive compensation plan?

    Yes, shareholders provided a non-binding advisory vote in favor of the company's executive compensation.

  3. Who will serve as Centene's independent auditor for the upcoming fiscal year?

    KPMG LLP has been ratified as the independent registered public accounting firm for Centene for the fiscal year ending December 31, 2026.

  4. Was the shareholder proposal for an independent board chairman successful?

    No, the shareholder proposal requesting an independent board chairman was not approved by the shareholders.